Microsoft Corporation (MSFT) Closes 1.47% Up on the Day for December 29

Equities Staff |

Dow Jones component Microsoft Corporation (MSFT) saw its stock move 1.47% to $56.77, representing a per-share move of $0.8236, on volume of 20.12 million shares for Tuesday.

Microsoft Corporation currently has a total float of 7.99 billion shares and moves 35.01 million a day, on average. The stock opened at $56.29 on December 29 and traded between a low of $56.06 and a high of $56.85. The stock now has a 50-day SMA of $53.59 and 200-day SMA of $46.76, and it has a high of $56.79 and low of $39.72 over the last year.

Microsoft Corp is engaged in designing, manufacturing, selling devices, and online advertising. Its products include operating systems for computing devices, servers, phones and other devices.

Based out of Redmond, WA, Microsoft Corporation has 118,000 employees and is helmed by CEO Satya Nadella.

For a deeper dive into the fundamentals of Microsoft Corporation, check out’s E.V.A. report for MSFT.


The Dow Jones Industrial Average is the oldest and most-often cited stock market index for the American equities market. While it’s arguably outdated and inefficient, it remains the most visible representation of the stock market to the outside world. Consisting of 30 companies selected by the editorial board of the Wall Street Journal, it’s meant to give an overview of stock performances by looking at a slice of those mega- and large-cap companies deemed to best represent the broad economy.

The history of the index dates all the way back to 1896 when it was first created by Charles Dow, the legendary founding editor of the Wall Street Journal and founder of Dow Jones & Company, and Edward Jones, a statistician. The price-weighted, scaled index has since become a standard part of most major daily news recaps and has seen dozens of different companies pass through its ranks, with only General Electric (GE) remaining on the index since its inception.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…